In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy

Triple negative breast cancer (TNBC) patients exhibit poor survival outcomes and lack effective targeted therapies. Using unbiased in vivo genome-wide CRISPR screening, we interrogated cancer vulnerabilities in TNBC and identified an interplay between oncogenic and tumor suppressor pathways. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Meiou, Yan, Gang, Wang, Ni, Daliah, Girija, Edick, Ashlin M., Poulet, Sophie, Boudreault, Julien, Ali, Suhad, Burgos, Sergio A., Lebrun, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144221/
https://www.ncbi.nlm.nih.gov/pubmed/34031411
http://dx.doi.org/10.1038/s41467-021-23316-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144221/
https://www.ncbi.nlm.nih.gov/pubmed/34031411
http://dx.doi.org/10.1038/s41467-021-23316-4

Ejemplares similares